Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences: //--> Brisbane, California, February 28, 2020 – Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported fourth quarter and full year 2019 financial results and recent business … new Date().getFullYear()>2010&&document.write(new Date().getFullYear()); Sangamo Therapeutics, Inc. Common Stock (SGMO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Footer menu. Investors Overview; Why Invest - Our Story . [CDATA[> Sangamo … The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. Disease Conditions. Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. Originally published December 7, 2020, 7:00 AM. Financials ... ewolffe@sangamo.com. Find the latest SEC Filings data for Sangamo Therapeutics, Inc. Common Stock (SGMO) at Nasdaq.com. Conference Call and Webcast Scheduled for 8 a.m. Eastern Time . © Corporate Profile. Sandy Macrae-- President and Chief Executive Officer.